Beiersdorf's shares reached their highest level since early 2020, with the company's new CEO, Vincent Warnery, expressing optimism about the company's future growth. Under the previous leadership of Stefan de Loecker... Beiersdorf made significant investments in its consumer business to revitalize slowing sales growth.
The company also acquired the U.S. sun care brand Coppertone from Bayer for $550 million to strengthen its presence in North America. Beiersdorf's earnings before interest and tax (EBIT) margin widened to 15.3% in the first half, compared to 13.7% in the same period last year. However, "the company expects its full-year margin to remain flat at around 12."9%, due to rising material costs and investments in digitization and innovation.
Some analysts have raised concerns about Beiersdorf's guidance, "suggesting that the company's recovery may slow down in the second half of the year.".. accompanied by a significant reduction in profitability.
Nivea Maker Beiersdorf Enjoys Big Sales Boost
• **Surpassing pre-pandemic levels**: Beiersdorf's sales have risen above pre-pandemic levels, with organic sales jumping 28.3% in the second quarter and 16.2% for the first half of the year, achieving revenue of €3.87 billion. 2. **Strong growth in key brands**: Analysts at Jefferies note that the company's growth was driven by strong performance in its three key brands: Nivea, La Prairie, and Derma. 3. **Investments in consumer business and international expansion**: Beiersdorf's previous CEO invested more in its consumer business to revive slowing sales growth and acquired the U.S. sun care brand Coppertone from Bayer for $550 million to strengthen its position in North America. 4. **Concerns about future profitability**: Bernstein analyst Bruno Monteyne warns that Beiersdorf's guidance implies a slowdown in the recovery in the second half of the year, accompanied by a significant reduction in profitability due to rising material prices and investments in digitization and innovation.
BERLIN (Reuters) - Nivea maker Beiersdorf's sales rose above pre-pandemic levels as demand for adhesives and its dermatological brands roared back, pushing the shares up by more than 5% in early trade on Thursday. Organic sales jumped 28.3% in the second quarter to deliver growth for the first half of 16.2%, achieving 3.87 billion euros revenue, a tad above the consensus estimate of 3.82 billion according to Refinitiv IBES data and the 2019 first-half figure of 3.84 billion euros.